<!DOCTYPE html>
<html>
<head>
<title>MaxLinear, Inc. Annual report pursuant to Section 13 and 15(d)</title>
<link href="https://investors.maxlinear.com/stylesheets/ir.stockpr.css" rel="stylesheet" type="text/css">
<script type="text/javascript" src="https://investors.maxlinear.com/javascripts/ir.js"></script>
<link rel="stylesheet" type="text/css" href="https://ir.stockpr.com/stylesheets/xbrl.css">
<script type="text/javascript" src="https://ir.stockpr.com/javascripts/xbrl.min.js"></script>
<script type="text/javascript" src="https://ir.stockpr.com/javascripts/xbrl.js"></script>
</head>
<body>
<style>
body {
font-family: Arial, Helvetica, sans-serif;
font-size: 12px;
color: #454545;
}
</style>
<div class="xbrl-content">
    <h3>Annual report pursuant to Section 13 and 15(d)</h3>
    <div id="xbrl-menu-top">
        <div class="navigation">
            <ul class="xbrl-sf-menu">
                
                    <li>
                        <a class="menu-item " href="https://investors.maxlinear.com/annual-reports/xbrl_doc_only/132">Cover</a>
                        <ul class="submenu">
                                                            <li><a href="https://investors.maxlinear.com/annual-reports/xbrl_doc_only/132">Document and Entity Information</a></li>
                                                    </ul>
                    </li>
                                    <li>
                        <a class="menu-item " href="https://investors.maxlinear.com/annual-reports/xbrl_doc_only/133">Financial Statements</a>
                        <ul class="submenu">
                                                            <li><a href="https://investors.maxlinear.com/annual-reports/xbrl_doc_only/133">CONSOLIDATED BALANCE SHEETS</a></li>
                                                            <li><a href="https://investors.maxlinear.com/annual-reports/xbrl_doc_only/134">CONSOLIDATED BALANCE SHEETS (Parenthetical)</a></li>
                                                            <li><a href="https://investors.maxlinear.com/annual-reports/xbrl_doc_only/135">CONSOLIDATED STATEMENTS OF OPERATIONS</a></li>
                                                            <li><a href="https://investors.maxlinear.com/annual-reports/xbrl_doc_only/136">CONSOLIDATED STATEMENTS OF OPERATIONS (Parenthetical)</a></li>
                                                            <li><a href="https://investors.maxlinear.com/annual-reports/xbrl_doc_only/137">CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS)</a></li>
                                                            <li><a href="https://investors.maxlinear.com/annual-reports/xbrl_doc_only/138">CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS) (Parenthetical)</a></li>
                                                            <li><a href="https://investors.maxlinear.com/annual-reports/xbrl_doc_only/139">CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (DEFICIT)</a></li>
                                                            <li><a href="https://investors.maxlinear.com/annual-reports/xbrl_doc_only/140">CONSOLIDATED STATEMENTS OF CASH FLOWS</a></li>
                                                    </ul>
                    </li>
                                    <li>
                        <a class="menu-item " href="https://investors.maxlinear.com/annual-reports/xbrl_doc_only/141">Notes to Financial Statements</a>
                        <ul class="submenu">
                                                            <li><a href="https://investors.maxlinear.com/annual-reports/xbrl_doc_only/141">Schedule II - Valuation and Qualifying Accounts</a></li>
                                                            <li><a href="https://investors.maxlinear.com/annual-reports/xbrl_doc_only/142">Organization and Summary of Significant Accounting Policies</a></li>
                                                            <li><a href="https://investors.maxlinear.com/annual-reports/xbrl_doc_only/143">Net Income (Loss) per Share</a></li>
                                                            <li><a href="https://investors.maxlinear.com/annual-reports/xbrl_doc_only/144">Financial Instruments</a></li>
                                                            <li><a href="https://investors.maxlinear.com/annual-reports/xbrl_doc_only/145">Balance Sheet Details</a></li>
                                                            <li><a href="https://investors.maxlinear.com/annual-reports/xbrl_doc_only/146">Commitments and Contingencies</a></li>
                                                            <li><a href="https://investors.maxlinear.com/annual-reports/xbrl_doc_only/147">Stock-Based Compensation, Employee Benefit Plans and Convertible Preferred Stock</a></li>
                                                            <li><a href="https://investors.maxlinear.com/annual-reports/xbrl_doc_only/148">Income Taxes</a></li>
                                                            <li><a href="https://investors.maxlinear.com/annual-reports/xbrl_doc_only/149">Employee Retirement Plan</a></li>
                                                            <li><a href="https://investors.maxlinear.com/annual-reports/xbrl_doc_only/150">Related-Party Transactions</a></li>
                                                            <li><a href="https://investors.maxlinear.com/annual-reports/xbrl_doc_only/151">Selected Quarterly Financial Data (Unaudited)</a></li>
                                                    </ul>
                    </li>
                                    <li>
                        <a class="menu-item " href="https://investors.maxlinear.com/annual-reports/xbrl_doc_only/152">Accounting Policies</a>
                        <ul class="submenu">
                                                            <li><a href="https://investors.maxlinear.com/annual-reports/xbrl_doc_only/152">Organization and Summary of Significant Accounting Policies (Policies)</a></li>
                                                    </ul>
                    </li>
                                    <li>
                        <a class="menu-item " href="https://investors.maxlinear.com/annual-reports/xbrl_doc_only/153">Notes Tables</a>
                        <ul class="submenu">
                                                            <li><a href="https://investors.maxlinear.com/annual-reports/xbrl_doc_only/153">Organization and Summary of Significant Accounting Policies (Tables)</a></li>
                                                            <li><a href="https://investors.maxlinear.com/annual-reports/xbrl_doc_only/154">Net Income (Loss) per Share (Tables)</a></li>
                                                            <li><a href="https://investors.maxlinear.com/annual-reports/xbrl_doc_only/155">Financial Instruments (Tables)</a></li>
                                                            <li><a href="https://investors.maxlinear.com/annual-reports/xbrl_doc_only/156">Balance Sheet Details (Tables)</a></li>
                                                            <li><a href="https://investors.maxlinear.com/annual-reports/xbrl_doc_only/157">Commitments and Contingencies (Tables)</a></li>
                                                            <li><a href="https://investors.maxlinear.com/annual-reports/xbrl_doc_only/158">Stock-Based Compensation, Employee Benefit Plans and Convertible Preferred Stock (Tables)</a></li>
                                                            <li><a href="https://investors.maxlinear.com/annual-reports/xbrl_doc_only/159">Income Taxes (Tables)</a></li>
                                                            <li><a href="https://investors.maxlinear.com/annual-reports/xbrl_doc_only/160">Selected Quarterly Financial Data (Unaudited) (Tables)</a></li>
                                                    </ul>
                    </li>
                                    <li>
                        <a class="menu-item current" href="https://investors.maxlinear.com/annual-reports/xbrl_doc_only/161">Notes Details</a>
                        <ul class="submenu">
                                                            <li><a href="https://investors.maxlinear.com/annual-reports/xbrl_doc_only/161">Schedule II - Valuation and Qualifying Accounts (Detail)</a></li>
                                                            <li><a href="https://investors.maxlinear.com/annual-reports/xbrl_doc_only/162">Organization and Summary of Significant Accounting Policies - Additional Information (Detail)</a></li>
                                                            <li><a href="https://investors.maxlinear.com/annual-reports/xbrl_doc_only/163">Organization and Summary of Significant Accounting Policies - Customers Greater Than Ten Percent of Net Revenue (Detail)</a></li>
                                                            <li><a href="https://investors.maxlinear.com/annual-reports/xbrl_doc_only/164">Organization and Summary of Significant Accounting Policies - Customers Greater Than Ten Percent of Net Revenue (Parenthetical) (Detail)</a></li>
                                                            <li><a href="https://investors.maxlinear.com/annual-reports/xbrl_doc_only/165">Organization and Summary of Significant Accounting Policies - Products Shipped to International Destinations Representing Greater Than Ten Percent of Net Revenue (Detail)</a></li>
                                                            <li><a href="https://investors.maxlinear.com/annual-reports/xbrl_doc_only/166">Organization and Summary of Significant Accounting Policies - Balances Greater Than Ten Percent of Accounts Receivable (Detail)</a></li>
                                                            <li><a href="https://investors.maxlinear.com/annual-reports/xbrl_doc_only/167">Organization and Summary of Significant Accounting Policies - Balances Greater Than Ten Percent of Accounts Receivable (Parenthetical) (Detail)</a></li>
                                                            <li><a href="https://investors.maxlinear.com/annual-reports/xbrl_doc_only/168">Net Income (Loss) Per Share - Additional Information (Detail)</a></li>
                                                            <li><a href="https://investors.maxlinear.com/annual-reports/xbrl_doc_only/169">Net Income (Loss) Per Share - Summary of Basic and Diluted Earnings Per Share (Detail)</a></li>
                                                            <li><a href="https://investors.maxlinear.com/annual-reports/xbrl_doc_only/170">Financial Instruments - Composition of Financial Instruments (Detail)</a></li>
                                                            <li><a href="https://investors.maxlinear.com/annual-reports/xbrl_doc_only/171">Financial Instruments - Additional Information (Detail)</a></li>
                                                            <li><a href="https://investors.maxlinear.com/annual-reports/xbrl_doc_only/172">Financial Instruments - Financial Instruments Measured on Recurring Basis (Detail)</a></li>
                                                            <li><a href="https://investors.maxlinear.com/annual-reports/xbrl_doc_only/173">Balance Sheet Details - Inventory (Detail)</a></li>
                                                            <li><a href="https://investors.maxlinear.com/annual-reports/xbrl_doc_only/174">Balance Sheet Details - Property and Equipment (Detail)</a></li>
                                                            <li><a href="https://investors.maxlinear.com/annual-reports/xbrl_doc_only/175">Balance Sheet Details - Intangible Assets (Detail)</a></li>
                                                            <li><a href="https://investors.maxlinear.com/annual-reports/xbrl_doc_only/176">Balance Sheet Details - Amortization of Company's Intangible Assets (Detail)</a></li>
                                                            <li><a href="https://investors.maxlinear.com/annual-reports/xbrl_doc_only/177">Balance Sheet Details - Deferred Revenue and Deferred Profit (Detail)</a></li>
                                                            <li><a href="https://investors.maxlinear.com/annual-reports/xbrl_doc_only/178">Balance Sheet Details - Accrued Expenses (Detail)</a></li>
                                                            <li><a href="https://investors.maxlinear.com/annual-reports/xbrl_doc_only/179">Balance Sheet Details - Other Long-Term Liabilities (Detail)</a></li>
                                                            <li><a href="https://investors.maxlinear.com/annual-reports/xbrl_doc_only/180">Commitments and Contingencies - Additional Information (Detail)</a></li>
                                                            <li><a href="https://investors.maxlinear.com/annual-reports/xbrl_doc_only/181">Commitments and Contingencies - Future Minimum Annual Payments Under Non-Cancelable Operating Leases, Other Obligations and Inventory Purchase Obligations (Detail)</a></li>
                                                            <li><a href="https://investors.maxlinear.com/annual-reports/xbrl_doc_only/182">Stock-Based Compensation, Employee Benefit Plans and Convertible Preferred Stock - Additional Information (Detail)</a></li>
                                                            <li><a href="https://investors.maxlinear.com/annual-reports/xbrl_doc_only/183">Stock-Based Compensation, Employee Benefit Plans and Convertible Preferred Stock - Stock-Based Compensation (Detail)</a></li>
                                                            <li><a href="https://investors.maxlinear.com/annual-reports/xbrl_doc_only/184">Stock-Based Compensation, Employee Benefit Plans and Convertible Preferred Stock - Fair Values of Stock Options (Detail)</a></li>
                                                            <li><a href="https://investors.maxlinear.com/annual-reports/xbrl_doc_only/185">Stock-Based Compensation, Employee Benefit Plans and Convertible Preferred Stock - Fair Value of Employee Stock Purchase Rights (Detail)</a></li>
                                                            <li><a href="https://investors.maxlinear.com/annual-reports/xbrl_doc_only/186">Stock-Based Compensation, Employee Benefit Plans and Convertible Preferred Stock - Summary of Company's Stock Option Activity (Detail)</a></li>
                                                            <li><a href="https://investors.maxlinear.com/annual-reports/xbrl_doc_only/187">Stock-Based Compensation, Employee Benefit Plans and Convertible Preferred Stock - Summary of Restricted Stock Unit and Restricted Stock Award Activity (Detail)</a></li>
                                                            <li><a href="https://investors.maxlinear.com/annual-reports/xbrl_doc_only/188">Stock-Based Compensation, Employee Benefit Plans and Convertible Preferred Stock - Common Stock Reserved for Future Issuance (Detail)</a></li>
                                                            <li><a href="https://investors.maxlinear.com/annual-reports/xbrl_doc_only/189">Income Taxes - Components of Income (Loss) Before Provision (Benefit) from Income Taxes (Detail)</a></li>
                                                            <li><a href="https://investors.maxlinear.com/annual-reports/xbrl_doc_only/190">Income Taxes - Components of Income Tax Provision (Benefit) (Detail)</a></li>
                                                            <li><a href="https://investors.maxlinear.com/annual-reports/xbrl_doc_only/191">Income Taxes - Actual Income Tax Provision (Benefit) Differs from Amount Computed Using Federal Statutory Rate (Detail)</a></li>
                                                            <li><a href="https://investors.maxlinear.com/annual-reports/xbrl_doc_only/192">Income Taxes - Components of Deferred Income Tax Assets (Detail)</a></li>
                                                            <li><a href="https://investors.maxlinear.com/annual-reports/xbrl_doc_only/193">Income Taxes - Additional Information (Detail)</a></li>
                                                            <li><a href="https://investors.maxlinear.com/annual-reports/xbrl_doc_only/194">Income Taxes - Summary of Changes to Unrecognized Tax Benefits (Detail)</a></li>
                                                            <li><a href="https://investors.maxlinear.com/annual-reports/xbrl_doc_only/195">Related-Party Transactions - Additional Information (Detail)</a></li>
                                                            <li><a href="https://investors.maxlinear.com/annual-reports/xbrl_doc_only/196">Selected Quarterly Financial Data (Unaudited) - Schedule of Quarterly Financial Information (Detail)</a></li>
                                                            <li><a href="https://investors.maxlinear.com/annual-reports/xbrl_doc_only/197">Selected Quarterly Financial Data (Unaudited) - Schedule of Quarterly Financial Information (Parenthetical) (Detail)</a></li>
                                                    </ul>
                    </li>
                            </ul>
        </div>
    </div>
    <div class="spr-xbrl-document">
        <h4>Income Taxes - Components of Deferred Income Tax Assets (Detail)</h4>
                <div style="clear:both;"></div>
    </div>
</div>
</body>
</html>